Table 2. The clinicopathological relevance analysis of miR-26a and KRT19 expression in cholangiocarcinoma patients.

	miR-26a			KRT19
Characteristic	Low	High	Pvalue	Low	High	Pvalue
All cases	33	32		32	33
Age			0.714			0.714
<60	15	16		16	15
≥60	18	16		16	18
Gender			0.725			0.228
Male	22	20		23	19
Female	11	12		9	14
Differentiation grade			0.897			0.367
Well	21	22		23	20
Moderate	8	7		5	10
Poorly	4	3		4	3
Tumor Size (cm)			0.035			0.002
≤5 cm	12	20		22	10
>5 cm	21	12		10	23
Tumor Origination			0.915			0.995
Left	13	11		12	12
Right	19	20		19	20
Bilateral	1	1		1	1
TNM stage			0.694			0.371
I–II	18	19		20	17
III	15	13		12	16
Metastasis			0.909			0.379
Yes	18	17		19	16
No	15	15		13	17